Medigen Vaccine Biologics Market Cap

Medigen Vaccine Biologics has a market cap or net worth of 16.12 billion as of January 31, 2025. Its market cap has decreased by -28.89% in one year.

Market Cap

16.12B

Enterprise Value

14.66B

Revenue

648.17M

Ranking

n/a

PE Ratio

n/a

Stock Price

49.05

Market Cap Chart

Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 16.12B, an increase of 468.76%. That is a compound annual growth rate of 20.15%.

Market Cap History

Date	Market Cap	% Change
Jan 22, 2025	16.12B	36.06%
Dec 31, 2024	11.85B	-48.55%
Dec 29, 2023	23.04B	1.10%
Dec 30, 2022	22.78B	-64.20%
Dec 30, 2021	63.65B	192.75%
Dec 31, 2020	21.74B	388.97%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	228.69B
Caliway Biopharmaceuticals	107.10B
Bora Pharmaceuticals Co., LTD.	83.09B
Lotus Pharmaceutical	68.47B
Lumosa Therapeutics	40.03B
Oneness Biotech	37.72B
Polaris Group	33.47B
Center Laboratories	29.00B

Market Cap Rankings